(Q43729199)
Statements
1 reference
Daclizumab (humanized anti-IL2Ralpha mAb) prophylaxis for prevention of acute rejection in renal transplant recipients with delayed graft function (English)
1 reference
G L Bumgardner
1 reference
E Ramos
1 reference
A Lin
1 reference
F Vincenti
1 reference
Daclizumab Triple Therapy and Double Therapy Groups
1 reference
1 August 2001
1 reference
1 reference
72
1 reference
4
1 reference
642-647
1 reference
Identifiers
1 reference
1 reference